Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma

NCT03821077 · clinicaltrials.gov ↗

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic
Rhinoconjunctivitis

Interventions

BIOLOGICAL: Allergen Immunotherapy (AIT)

Sponsor

Roxall Medicina España S.A